Elena G. Gavrilova

Elena G. Gavrilova

Auto-generated profile, based on publicly available information

Elena G. Gavrilova

Pavlov University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2021 in Cells
Verified
Journal Article
Open access
PDF file
IVIvan Vlasov
Ivan Vlasov
APAlexandra Panteleeva
Alexandra Panteleeva
TUTatiana Usenko
Tatiana Usenko
MNMikhael Nikolaev
Mikhael Nikolaev
AIArtem Dmitrievich Izyumchenko
Artem Dmitrievich Izyumchenko
Pyotr A. SlominskyPyotr A. Slominsky
Pyotr A. Slominsky
To assess the biology of the lethal endpoint in patients with SARS-CoV-2 infection, we compared the transcriptional response to the virus in patients who survived or died during severe COVID-19. We applied gene expression profiling to generate transcriptional signatures for peripheral blood mononuclear cells (PBMCs) from patients with SARS-CoV-2 infection at the time when they were placed in the Intensive Care Unit of the Pavlov First State Medical University of St. Petersburg (Russia). Three different bioinformatics approaches to RNA-seq analysis identified a downregulation of three common pathways in survivors compared with nonsurvivors among patients with severe COVID-19, namely, low-density lipoprotein (LDL) particle receptor activity (GO:0005041), important for maintaining cholesterol homeostasis, leukocyte differentiation (GO:0002521), and cargo receptor activity (GO:0038024). Specifically, PBMCs from surviving patients were characterized by reduced expression of PPARG, CD36, STAB1, ITGAV, and ANXA2. Taken together, our findings suggest that LDL particle receptor pathway activity in patients with COVID-19 infection is associated with poor disease prognosis.

13 May 2022 in The Scientific Notes of the Pavlov University
Verified
Journal Article
Open access
PDF file
OSOlga Sirotkina
Olga Sirotkina
AUA. S. Ulitina
A. S. Ulitina
DKDaria Kulabukhova
Daria Kulabukhova
MNMikhael Nikolaev
Mikhael Nikolaev
AIArtem Dmitrievich Izyumchenko
Artem Dmitrievich Izyumchenko
SPSofia Pchelina
Sofia Pchelina
Introduction. In recent years, much attention has been paid to the study of extracellular microparticles (microvesicles and exosomes) and their role in the pathogenesis of human diseases.The objective of this study was to determine the number and size of plasma extracellular microparticles (PEMP) in patients with severe and extremely severe COVID-19 and correlate these data with the markers of hemostasis activation, inflammation, and tissue damage.Methods and Materials. The study included 29 patients with severe and extremely severe COVID-19. Concentration and size of PEMP were determined by nanoparticle trajectory analysis (NTA). All patients underwent the complete blood count and the thromboelastometry (TEM). Hemostatic, biochemical, and immunological parameters were assessed including fibrinogen, prothrombin time, activated partial thromboplastin time, D-dimer, C-reactive protein, lactate dehydrogenase, procalcitonin, von Willebrand factor antigen, interleukin 6, and interleukin 18.Results. There were 14 patients (48.3 %) discharged from the ICU with improvement (group 1— survived patients), and 15 patients (51.7 %) with lethal outcomes (group 2 — lethal outcome); the PEMP concentration did not differ between these groups. In group 2, there were heterogeneity of PEMP population, and a tendency to the larger PEMP size (p=0.074). In all patients, the PEMP concentration correlated negatively with both prothrombin time and the number of large platelets; the size of PEMP correlated negatively with the level of von Willebrand factor antigen, and positively with the fibrinogen. In group 1, the PEMP concentration had a direct correlation with both the level of interleukin 18 and maximum clot lysis in TEM; the PEMP size had a direct correlation with the maximum clot lysis in TEM and an inverse correlation with both the level of procalcitonin and maximum clot density in TEM.Conclusion. Our study confirms the importance of the process of extracellular microparticles formation in the COVID-19 pathogenesis. Our findings are consistent with the hypothesis that the parameters of PEMP population can be predictive biomarkers of the COVID-19 severity.

1 January 2022 in Immunologiya
Verified
Journal Article
Closed access
PFPavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of the Russian Federation
Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of the Russian Federation
MPM.YU. Pervakova
M.YU. Pervakova
VPV.G. Potapenko
V.G. Potapenko
SPSaint-Petersburg State Budgetary Healthcare Institution «Municipal Clinical Hospital No. 31» of the Health Committee of Saint Petersburg
Saint-Petersburg State Budgetary Healthcare Institution «Municipal Clinical Hospital No. 31» of the Health Committee of Saint Petersburg
OTO.YU. Tkachenko
O.YU. Tkachenko
VEV.L. Emanuel
V.L. Emanuel
Цитокиновые паттерны летальных гипервоспалительных состояний, индуцированных вторичным гемофагоцитарным синдромом, бактериальным сепсисом и COVID-19

9 September 2020 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
ISI. V. Shlyk
I. V. Shlyk
ASA. A. Streltsova
A. A. Streltsova
VTV. M. Teplov
V. M. Teplov
EGE. G. Gavrilova
E. G. Gavrilova
AKAlexandr Nicolaevich Kulikov
Alexandr Nicolaevich Kulikov
AGA. Ya. Gudkova
A. Ya. Gudkova
Кардиомиопатия со смешанным фенотипом, ассоциированная с вариантом в гене DSP (клинико-морфологическое наблюдение и обзор сведений литературы)

3 May 2021 in Messenger of ANESTHESIOLOGY AND RESUSCITATION
Verified
Journal Article
Open access
PDF file
KKK. N. Khrapov
K. N. Khrapov
AKA. A. Khryapa
A. A. Khryapa
IVI. V. Vartanova
I. V. Vartanova
SSS. S. Sedov
S. S. Sedov
YOYu. S. Okhapina
Yu. S. Okhapina
EGE. G. Gavrilova
E. G. Gavrilova
Представлен клинический случай развития анафилактического шока у пациента, которому планировали выполнить оперативное вмешательство на позвоночнике. Через 10 мин после введения в анестезию у пациента развились выраженная гипотензия (резистентная к введению адреномиметиков), тахикардия, снижение парциального давления углекислого газа в конце выдоха. Вследствие быстрого развития критического состояния, отсутствия специфических кожных проявлений и аллергологического анамнеза, а также прямой связи с введением конкретного агента потребовалось проводить дифференциальную диагностику между острым инфарктом миокарда, тромбоэмболией легочной артерии и анафилактическим шоком. На фоне проведения интенсивной терапии больному выполнили ЭКГ-исследование, эхокардиографию, анализ газового состава крови. Решающим диагностическим фактором оказалось выявление признаков бронхоспазма. При стабилизации состояния выполнили ангиографию сосудов сердца и легких, позднее был установлен агент, вызвавший развитие анафилаксии. Выявление причины гипотензии после индукции анестезии имеет решающее значение, поскольку терапия может существенно отличаться. Развитие анафилактического шока во время общей анестезии не является частым событием, но несвоевременная диагностика и задержка в проведении терапии могут привести к фатальному исходу. В статье на примере представленного клинического случая обсуждаются современные подходы к диагностике и терапии периоперационной анафилаксии.

23 August 2021 in Therapy
Verified
Journal Article
Closed access
TTTkachenko O.YU. Tkachenko
Tkachenko O.YU. Tkachenko
PPPervakova M.YU. Pervakova
Pervakova M.YU. Pervakova
SLSergey V. Lapin
Sergey V. Lapin
MMMasing A.V. Masing
Masing A.V. Masing
MMMoshnikova A.N. Moshnikova
Moshnikova A.N. Moshnikova
IRI.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of Russia
I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of Russia